Article
Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.
Hepatobiliary & pancreatic diseases international : HBPD INT - 1 Aug 2008
Lu An-Wei, Zheng Shu-Sen, Wu Mei-Ping, Shen Yi, Yang Rong-Wei
Abstract excerpt
BACKGROUND: Hepatitis B virus (HBV) recurrence may result in hepatic insufficiency or dysfunction of liver grafts. This study was to reevaluate the preventive effect of lamivudine therapy pretransplant on HBV recurrence after liver transplantation with combined lamivudine and hepatitis B immunoglobulin (HBIG) as a prophylactic regimen. METHODS: This is a single-center, retrospective study of 122 liver transplant...
Topics
- DNA, Viral
- Drug Administration Schedule
- Drug Therapy, Combination
- Glucocorticoids
- Hepatitis B
- Hepatitis B Antibodies
- Hepatitis B virus
- Humans
- Immunoglobulins
- Immunosuppressive Agents
